Dow Jones
32.425,63 +181,05 (+0,56%) Nasdaq
11.806,88 +131,34 (+1,12%) Nikkei 225
26.945,67 -388,12 (-1,42%) EUR/USD
1,0764 +0,0038 (+0,36%) Bitcoin EUR
26.165,62 +313,01 (+1,21%) CMC Crypto 200
612,04 +6,99 (+1,16%)
Orion Oyj (0M2N.L)
| Chiusura precedente | 43,85 |
| Aperto | 44,00 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 43,35 - 44,10 |
| Intervallo di 52 settimane | 43,35 - 44,10 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | 55,622M |
| Beta (5 anni mensile) | 0,48 |
| Rapporto PE (ttm) | 0,32 |
| EPS (ttm) | 1,36 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Orion Corporation: Charman of the Nomination Committee changes
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE21 March 2023 at 17:45 EET Orion Corporation: Charman of the Nomination Committee changes After being elected as Chairman of the Board of Directors of Oriola Corporation the Chairman of the Nomination Committee of Orion Corporation Heikki Westerlund has resigned from the Nomination Committee of Orion Corporation. The Board of Directors of Orion Corporation has appointed Timo Maasilta as t
- GlobeNewswire
Darolutamide approved for additional prostate cancer indication in China
ORION CORPORATION PRESS RELEASE 20 March 2023 at 09:00 EET Darolutamide approved for additional prostate cancer indication in China Darolutamide now approved for metastatic hormone-sensitive prostate cancer as well as non-metastatic castration-resistant prostate cancer Additional indication based on data from the pivotal Phase III ARASENS trial The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi) darolutamide in combination with doce
- GlobeNewswire
Orion Corporation: Managers’ transactions – Kari Jussi Aho
ORION CORPORATION MANAGERS’ TRANSACTIONS 9 MARCH 2023 at 11.30 EET Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Kari Ju
